Abstract 3260: Potentiation of Type I interferon signaling leads to <i>in vivo</i> efficacy achieved with combination of chemotherapy and the PARP7 inhibitor RBN-2397

Authors: Kaiko Kunii, Jeff J. Song, Danielle Zimmerman, Chang Liu, Kristy G. Kuplast-Barr, Jonathan J. Novak, Sunaina P. Nayak, Joseph M. Gozgit, Melissa M. Vasbinder, Kristen McEachern, Kevin W. Kuntz, Heike Keilhack, Jennifer R. Molina

Published: 2023-06-09

DOI: 10.1158/1538-7445.am2023-3260

Source: Full article


Abstract

Abstract